ICUI (ICU Medical) 1-Year Share Buyback Ratio : -1.00% (As of Mar. 2025 )

View and export this data going back to 1992. Start your Free Trial

What is ICU Medical 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. ICU Medical's current 1-Year Share Buyback Ratio was -1.00%.

ICUI's 1-Year Share Buyback Ratio is ranked better than
58.3% of 554 companies
in the Medical Devices & Instruments industry
Industry Median: -2.3 vs ICUI: -1.00

Competitive Comparison of ICU Medical's 1-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, ICU Medical's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ICU Medical's 1-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where ICU Medical's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

ICU Medical 1-Year Share Buyback Ratio Calculation

ICU Medical's 1-Year Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Mar. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Mar. 2024 )
	=	(24.365	-	24.611)	/	24.365
	=	-1.0%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICU Medical (NAS:ICUI) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

ICU Medical 1-Year Share Buyback Ratio Related Terms

ICU Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ICU Medical Inc (NAS:ICUI) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

951 Calle Amanecer, San Clemente, CA, USA, 92673

Website

https://www.icumed.com

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Executives

Christian B. Voigtlander	officer: Chief Operating Officer	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Elisha W Finney	director	C/O VARIAN MEDICAL SYSTEMS, INC, 3100 HANSEN WAY M/S E-327, PALO ALTO CA 94304
David C. Greenberg	director	951 CALLE AMANECER, SAN CLEMENTE CA 92887
Vivek Jain	director, officer: Chairman and CEO	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Daniel Woolson	officer: VP, GM-Infusion Capital	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Virginia Ruth Sanzone	officer: VP, General Counsel	951 CALLE AMANECER, SAN CLEMENTE CA 92673
George A Lopez	director, officer: Chairman, other: Chairman	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Smiths Group International Holdings Ltd	10 percent owner	C/O SMITHS GROUP PLC, 11-12 ST. JAMES'S SQUARE, 4TH FLOOR, LONDON X0 SW1Y 4LB
Group Plc Smiths	10 percent owner	765 FINCHKEY ROAD, LONDON X0 00000
William Seeger	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Kolleen T Kennedy	director	VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Robert S Swinney	director	C/O ICU MEDICAL, 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Laurie Hernandez	director	951 CALLE AMANECER, SAN CLEMENTE CA 92673
Brian Michael Bonnell	officer: Chief Financial Officer	ICU MEDICAL INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Scott E Lamb	officer: Controller	ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673